Dr. Hall on Multigene Target Panels for Genetic Weaknesses

• Michael Hall, MD, MS, director of gastrointestinal risk assessment and assistant professor at Fox Chase Cancer Center, was featured in an OncLive video on multigene target panels to determine genetic weaknesses.

  “Multigene panels have been developed for practitioners to evaluate tumors for genetic and genomic weaknesses,” Hall explains. “However, the fact that detected mutations within tumors are reflective of potential germline variations is understudied. This should be a significant area of research, because patients may be at risk for other cancers or may be unaware of risks associated with their family history.”